Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
MLYS
#1642
Mineralys Therapeutics, Inc. Common Stock
29.260
0
+3.12%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+3.12%
Variazione Mensile
-10.55%
Variazione di 6 mesi
-27.52%
Variazione Annuale
-27.52%
Chiusura Precedente
28.375
0
Open
29.260
0
Bid
Ask
Low
29.260
0
High
29.260
0
Volume
78
Mercati
Mercato Azionario Statunitense
Salute
MLYS
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
49.63 M
49.84 M
—
Valuation ratios
Enterprise value
381.49 M
499.39 M
4.95 B
Price to earnings ratio
-4.36
-3.36
-24.15
Price to sales ratio
—
—
—
Price to cash flow ratio
3.87
3.59
23.59
Price to book ratio
1.3
3.12
6.19
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
0.29
0.86
0.55
Return on equity %
0.3
0.93
0.58
Return on invested capital %
7 382.34
29.95 K
—
Gross margin %
—
—
—
Operating margin %
—
—
—
EBITDA margin %
—
—
—
Net margin %
—
—
—
Liquidity ratios
Quick ratio
—
—
—
Current ratio
23.76
14.02
81.13
Inventory turnover
—
—
—
Asset turnover
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
—
—
—
Long term debt to total equity ratio
—
—
—
Per share metrics
Operating cash flow per share
2.24
3.43
3.1
EBIT per share
—
—
—
EBITDA per share
—
—
—
Total debt per share
—
—
—
Cash per share
6.54
4.08
22.17
Net current asset value per share
6.88
4.23
24.52
Tangible book value per share
6.66
3.94
23.32
Working capital per share
6.59
3.93
23.29
Book value per share
6.66
3.94
23.32
Notizie
Rodman vende azioni Mineralys Therapeutics (MLYS) per 11.505 dollari
Rodman sells Mineralys Therapeutics (MLYS) stock for $11,505
Dirigente di Mineralys Therapeutics MLYS vende azioni per 569.000 dollari
Mineralys Therapeutics MLYS officer sells $569k in stock
Rodman vende azioni Mineralys (MLYS) per $13.353
Rodman sells Mineralys (MLYS) shares for $13,353
Levy, CFO di Mineralys Therapeutics, vende azioni MLYS per 345.000 dollari
Il CEO di Mineralys Therapeutics Congleton vende azioni MLYS per 529mila dollari
Dirigente di Mineralys Therapeutics MLYS vende azioni per 277mila dollari
Levy, Mineralys Therapeutics CFO, sells $345k in MLYS stock
Mineralys Therapeutics CEO Congleton sells $529k in MLYS stock
Mineralys Therapeutics MLYS officer sells $277k in stock